ATE229339T1 - Inhibitor der immunoglobulin e antikörpererzeugung zur behandlung von typ i allergie-verwandten krankheiten - Google Patents

Inhibitor der immunoglobulin e antikörpererzeugung zur behandlung von typ i allergie-verwandten krankheiten

Info

Publication number
ATE229339T1
ATE229339T1 AT98900051T AT98900051T ATE229339T1 AT E229339 T1 ATE229339 T1 AT E229339T1 AT 98900051 T AT98900051 T AT 98900051T AT 98900051 T AT98900051 T AT 98900051T AT E229339 T1 ATE229339 T1 AT E229339T1
Authority
AT
Austria
Prior art keywords
allergy
treatment
type
related diseases
immunoglobulin
Prior art date
Application number
AT98900051T
Other languages
English (en)
Inventor
Hitoshi Oomori
Yoichi Ooiso
Ryosuke Sugihara
Original Assignee
Tayca Corp
Hitoshi Oomori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tayca Corp, Hitoshi Oomori filed Critical Tayca Corp
Application granted granted Critical
Publication of ATE229339T1 publication Critical patent/ATE229339T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98900051T 1997-01-07 1998-01-05 Inhibitor der immunoglobulin e antikörpererzeugung zur behandlung von typ i allergie-verwandten krankheiten ATE229339T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9013125A JPH10194979A (ja) 1997-01-07 1997-01-07 イムノグロブリンｅ抗体産生抑制剤
PCT/JP1998/000029 WO1998030224A1 (en) 1997-01-07 1998-01-05 Inhibitor of immunoglobulin e antibody production

Publications (1)

Publication Number Publication Date
ATE229339T1 true ATE229339T1 (de) 2002-12-15

Family

ID=11824450

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98900051T ATE229339T1 (de) 1997-01-07 1998-01-05 Inhibitor der immunoglobulin e antikörpererzeugung zur behandlung von typ i allergie-verwandten krankheiten

Country Status (6)

Country Link
US (1) US6423320B1 (de)
EP (1) EP0894001B1 (de)
JP (1) JPH10194979A (de)
AT (1) ATE229339T1 (de)
DE (1) DE69810024T2 (de)
WO (1) WO1998030224A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE552120T1 (de) 2001-12-24 2012-04-15 L 1 Secure Credentialing Inc Verdeckte variableninformationen auf id- dokumenten und verfahren zu ihrer herstellung
WO2003088144A2 (en) 2002-04-09 2003-10-23 Digimarc Id Systems, Llc Image processing techniques for printing identification cards and documents
KR100615389B1 (ko) 2002-08-23 2006-08-25 (주)헬릭서 다래 추출물을 함유하는 알러지성 질환 및 비알러지성염증 질환의 예방 및 개선용 건강 기능 식품
US20100111927A1 (en) * 2002-08-23 2010-05-06 Sunyoung Kim Compositions Comprising Actinidia and Methods of Use Thereof
US20080175888A1 (en) * 2005-02-25 2008-07-24 Julie Lindemann Combination Therapy Comprising Actinidia and Steroids and Uses Thereof
JP5737646B2 (ja) * 2010-03-24 2015-06-17 森下仁丹株式会社 抗アレルギー剤
US10688169B2 (en) 2015-03-27 2020-06-23 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Vaccines against carbapenem-resistant Klebsiella pneumoniae

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870053A (en) * 1980-09-19 1989-09-26 Roussel Uclaf Novel compositions and processes
ATE72401T1 (de) * 1986-03-27 1992-02-15 Schweiz Serum & Impfinst Impfstoff des klebsiella kapsulpolysaccharids.
US4755381A (en) * 1986-03-27 1988-07-05 Swiss Serum And Vaccine Institute Berne Klebsiella capsular polysaccharide vaccine
FR2620130B1 (fr) 1987-09-08 1990-01-12 Lipha Nouveaux polysaccharides hydrosolubles, leur procede d'obtention, leur application a titre de medicaments et preparation les renfermant
AU5645090A (en) * 1989-05-04 1990-11-29 E.I. Du Pont De Nemours And Company Polymeric plasticizers for polyvinyl chloride
JPH0790003A (ja) * 1993-03-01 1995-04-04 Teika Corp 新規多糖類、その製造方法、新規多糖類の用途およびアゾトバクター・ベイジェリンキィーｔｎｍ１株
JP3453192B2 (ja) * 1994-06-01 2003-10-06 テイカ株式会社 新規多糖類、その製造方法、新規多糖類の用途およびアグロバクテリウム・ラディオバクターｔｎｍ２株
US5989874A (en) * 1995-03-27 1999-11-23 Tayca Corporation Humectant, antistatic agent, dispersant and film-forming agent having polysaccharide as active principle, preparation process of polysaccharides, and Kliebsiella ocytoca TNM-3 strain
WO1996039155A1 (fr) * 1995-06-05 1996-12-12 Tayca Corporation Immunostimulant

Also Published As

Publication number Publication date
DE69810024T2 (de) 2003-09-25
JPH10194979A (ja) 1998-07-28
US6423320B1 (en) 2002-07-23
US20020041885A1 (en) 2002-04-11
EP0894001B1 (de) 2002-12-11
WO1998030224A1 (en) 1998-07-16
EP0894001A1 (de) 1999-02-03
DE69810024D1 (de) 2003-01-23

Similar Documents

Publication Publication Date Title
NO2017027I1 (no) efmoroctocog alfa eller et biotilsvarende legemiddel ihht Artikkel 10(4) av Directive 2001/83/EC, som beskyttet av basispatentet.
TR199902120T2 (xx) Geli�mi� fotosentez sa�lamak i�in y�ntem
ES2062812T3 (es) Composicion detergente enzimatica y metodo para estabilizar enzimas.
CY1105836T1 (el) 12, 13-τροποποιημενα παραγωγα εποθιλονης
DE59813519D1 (de) Mutiertes ScFv-Fragment des OKT-3 Antikörpers
EE9900481A (et) Väikesed molekulid, mida kasutatakse põletikuliste haiguste raviks
AR248044A1 (es) Una secuencia de adn que codifica anticuerpos monoclonales humanizados contra interleuquinas humanas, metodo de obtencion y de seleccion de dichos anticuerpos, vector recombinante y celula huesped.
NO952989D0 (no) Fremgangsmåte til refolding av proteiner
DE69531218D1 (de) Verbesserung des ertrages von pflanzen
MX9800760A (es) Metodos para el tratamiento del asma alergica.
ATE310826T1 (de) Induktion von männlicher sterilität in pflanzen durch erhöhte expression von streptavidin
ATE140486T1 (de) Monoklonale antikörper (mak) gegen tumorassoziierte antigene, ihre herstellung und verwendung
ATE502050T1 (de) Von dd 3b6/22 abgeleitete humanisierte antikörper mit spezifität für das d-dimer fragment von fibrin
ATE229339T1 (de) Inhibitor der immunoglobulin e antikörpererzeugung zur behandlung von typ i allergie-verwandten krankheiten
DE3689766D1 (de) Monoklonaler antikörper-inhibitor des plasminogenaktivators, hybridomen, herstellung monoklonaler antikörper und deren verwendung zur reinigung, beseitigung, inhibition oder zum testverfahren von inhibitoren.
NO913078L (no) Oekt proteinproduksjon i dyr.
IT1184668B (it) Linfochina,suo anticorpo specifico monoclonale e relativo procedimento di produzione
DE60042273D1 (de) Antitumorantikörper, proteine und deren verwendung
FR2686898B1 (fr) Methode de production de la l-phenylalanine.
MX9300481A (es) Variedad mutante de maiz y metodo para su produccion.
ATE309371T1 (de) Protein mit dnase-aktivität
ATE361320T1 (de) Monoklonaler antikörper gegen protein c inhibitor
DE69118702D1 (de) Neue verwendung eines monoklonalen antikörpers
ATE291589T1 (de) Immunologische bindungsmoleküle, die die synzytiale fusion von trophoblastzellen hemmen
ATE231887T1 (de) Protein mit anti-tumorwirkung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties